Diseases [C] » Cardiovascular Diseases [C14] » Cardiovascular Abnormalities » Vascular Malformations
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Congenital Abnormalities » Cardiovascular Abnormalities » Vascular Malformations
Description
A spectrum of congenital, inherited, or acquired abnormalities in BLOOD VESSELS that can adversely affect the normal blood flow in ARTERIES or VEINS. Most are congenital defects such as abnormal communications between blood vessels (fistula), shunting of arterial blood directly into veins bypassing the CAPILLARIES (arteriovenous malformations), formation of large dilated blood blood-filled vessels (cavernous angioma), and swollen capillaries (capillary telangiectases). In rare cases, vascular malformations can result from trauma or diseases. MeSH
Hierarchy View
Subtype Terms (12)
Arteriovenous Malformations
14 drugs (11 approved, 3 experimental)
Central Nervous System Vascular Malformations
May-Thurner Syndrome
4 drugs (3 approved, 1 experimental)
Median Arcuate Ligament Syndrome
Persistent Left Superior Vena Cava
Pulmonary Atresia
2 drugs (1 approved, 1 experimental)
Telangiectasia, Hereditary Hemorrhagic
18 drugs (15 approved, 3 experimental)
Phase 3 Indicated Drugs (2)
Phase 2 Indicated Drugs (4)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 3 Indications (21)
Organization Involved with Phase 2 Indications (9)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
